Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the name given to the 2019 novel coronavirus. COVID-19 is the name given to the disease associated with the virus. SARS-CoV-2 is a new strain of coronavirus that has not been previously identified in humans. The 2019-Novel Coronavirus belongs to the genus β. It has a capsule, and its particles are round or oval, often polymorphous, with a diameter of 60-140nm. Its genetic characteristics are significantly different from SARS-CoV and MERS-CoV
2019-Novel Coronavirous (COVID-19) IgG/IgM GICA Rapid Test is a colloidal gold enhanced, rapid immunoassay for the qualitative detection of (COVID-19) IgG and IgM antibody in serum, plasma and whole blood samples from patients with suspected (COVID-19) infection, patients with suspected clustering cases, and others who need to diagnose or differentially diagnose 2019-Novel Coronavirous (COVID-19).
REAGENTS AND MATERIALS SUPPLIED
PRINCIPLE OF THE TEST
The product is pre-embedded with recombined 2019-nCoV antigen and chicken IgY antibody on the nitrocellulose membrane, and coated with anti-human IgM, anti-human IgG and goat anti-chicken IgY antibody respectively on the T1 line, T2 line and C line on the nitrocellulose membrane. When a positive sample is tested, the 2019-nCoV IgM and/or IgG antibody combines with the colloidal gold labeled 2019-nCoV antigen to form a complex. Under the action of chromatography, the complex flows along the membrane, when it passes T1 line and/or T2 line it combines with the anti-human IgM and/or IgG to form a colloidal gold complex to show color, and the gold colloidal labeled chicken IgY antibody combines with goat anti-chicken IgY antibody at C lint to show color. Negative samples only show color on C line.